Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
20.84
-15.84
-76.01%
Share Warrants & Outstandings
Total Reserve
765.35
2,141.54
-1,376.19
-64.26%
Shareholder's Funds
770.35
2,167.46
-1,397.11
-64.46%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-41.56
111.04
-152.60
-137.43%
Other Long Term Liabilities
38.45
107.56
-69.11
-64.25%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
6.32
23.41
-17.09
-73.00%
Total Non-Current Liabilities
3.21
242.00
-238.79
-98.67%
Current Liabilities
Trade Payables
456.30
332.65
123.65
37.17%
Other Current Liabilities
140.17
255.71
-115.54
-45.18%
Short Term Borrowings
0.00
128.64
-128.64
-100.00%
Short Term Provisions
106.53
10.20
96.33
944.41%
Total Current Liabilities
703.00
727.20
-24.20
-3.33%
Total Liabilities
1,476.56
3,136.66
-1,660.10
-52.93%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
162.41
1,542.44
-1,380.03
-89.47%
Less: Accumulated Depreciation
133.87
397.71
-263.84
-66.34%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
28.54
1,144.73
-1,116.19
-97.51%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
124.46
-124.46
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
114.18
-114.18
-100.00%
Long Term Loans & Advances
69.97
19.14
50.83
265.57%
Other Non Current Assets
0.00
6.83
-6.83
-100.00%
Total Non-Current Assets
134.21
1,642.12
-1,507.91
-91.83%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
548.50
118.33
430.17
363.53%
Sundry Debtors
184.88
352.87
-167.99
-47.61%
Cash and Bank
536.70
457.95
78.75
17.20%
Other Current Assets
16.20
441.27
-425.07
-96.33%
Short Term Loans and Advances
56.07
124.11
-68.04
-54.82%
Total Current Assets
1,342.35
1,494.54
-152.19
-10.18%
Net Current Assets (Including Current Investments)
639.35
767.35
-128.00
-16.68%
Total Current Assets Excluding Current Investments
1,342.35
1,494.54
-152.19
-10.18%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,476.56
3,136.66
-1,660.10
-52.93%
Contingent Liabilities
98.41
61.82
36.59
59.19%
Total Debt
0.00
128.64
-128.64
-100.00%
Book Value per share (adjusted)
308.14
104.00
204.14
196.29%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 38.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Annual - Fixed Assets
Fixed Assets 28.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,342.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
